Breaking Down Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd Financial Health: Key Insights for Investors

Crucial for investors weighing Xinjiang Xuefeng Sci‑Tech Co., Ltd. are unmistakable facts: first three quarters 2025 revenue fell to 4.183 billion yuan (down 8.28% YoY) while TTM revenue as of Mar 31, 2025 was 6.05 billion yuan with quarterly growth at -4.80%; profitability shows a TTM gross margin of 20.53%, net margin 10.06% and ROE of 8.90% even as EPS slid from 0.82 yuan (2023) to 0.62 yuan (2024) and Q1 2025 net income dropped to 65.16 million yuan from 125.25 million yuan; balance sheet and liquidity point to a conservative capital structure with a debt/equity of 0.12, net cash of 128.33 million yuan, a current ratio of 2.18 and an Altman Z‑Score of 4.37, while valuation metrics show a TTM P/E of 14.81, P/B 1.82 and market cap at 8.71 billion yuan (down 10.76% year‑over‑year) - dive into the full breakdown to see how these numbers, risks like raw‑material swings and regulatory pressure, plus growth moves such as the July 2025 Shengshi Putian acquisition and expanded production capacity of 697,500 tons, could affect investment decisions.

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) - Revenue Analysis

Xinjiang Xuefeng Sci-TechCo.,Ltd reported weakening top-line performance through early 2025, with the first three quarters' revenue totaling 4.183 billion yuan, a year-on-year decline of 8.28%. The company's trailing twelve months (TTM) revenue as of March 31, 2025 was 6.05 billion yuan, reflecting a quarterly revenue growth rate of -4.80%.

• First three quarters 2025 revenue: 4.183 billion yuan (YoY -8.28%).
• TTM revenue (to 2025-03-31): 6.05 billion yuan (quarterly growth -4.80%).
• Q1 2025 revenue: 1.12 billion yuan vs Q1 2024: 1.18 billion yuan (decline).
• TTM gross profit: 1.33 billion yuan - gross margin 20.53%.
• Revenue per share (latest quarter): 12.72 yuan.
• Market capitalization (2025-12-12): 8.71 billion yuan (12-month change -10.76%).

Key quarterly and TTM figures are summarized below for quick reference.

For historical context, ownership and broader corporate background relevant to revenue drivers, see: Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) Profitability Metrics

Key profitability indicators for Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) show mixed performance: margins and asset returns are positive but recent periods reflect declining earnings and operating income.

• Profitability levels: Net margin 10.06% and operating margin 9.00% indicate core operations remain profitable despite headwinds.
• Return metrics: ROE 8.90% and ROA 6.82% signal reasonable efficiency in using equity and assets.
• Earnings trend: EPS fell from 0.82 yuan (2023) to 0.62 yuan (2024), reflecting pressured bottom-line performance.
• Recent deterioration: H1 2025 operating income dropped 28% YoY to 743.5 million yuan; Q1 2025 net income declined to 65.16 million yuan from 125.25 million yuan a year earlier.

For strategic context and corporate priorities that may affect future profitability, see Mission Statement, Vision, & Core Values (2026) of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd.

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) - Debt vs. Equity Structure

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) exhibits a conservative capital structure characterized by low leverage, strong interest coverage and a net cash position. Key balance-sheet metrics and solvency indicators are summarized below and organized for investor-focused readability.

• Debt-to-equity ratio: 0.12 - indicates low financial leverage relative to shareholders' equity.
• Total debt: ¥669.54 million; net cash position: ¥128.33 million - company holds more cash (after netting) than short-term borrowings imply.
• Interest coverage ratio (EBIT / Interest): 35.12 - very strong ability to meet interest obligations from operating earnings.
• Equity (book value): ¥5.79 billion; book value per share: ¥4.60 - sizeable shareholder equity base.
• Enterprise value: ¥10.88 billion; EV / Revenue: 1.55 - market-implied valuation relative to top-line.
• Total liabilities: ¥1.90 billion vs. total assets: ¥8.36 billion - healthy asset base relative to obligations.

• Implication for investors: low leverage reduces bankruptcy risk and interest-rate sensitivity.
• Cash and coverage metrics provide flexibility for capex, dividends, or opportunistic buybacks.
• Moderate EV/Revenue (1.55) suggests valuation is neither extreme nor disconnective from fundamentals.

Further context and investor positioning can be explored here: Exploring Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd Investor Profile: Who's Buying and Why?

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) - Liquidity and Solvency

• Current ratio: 2.18 - indicates sufficient short-term assets to cover short-term liabilities.
• Quick ratio: 1.72 - suggests adequate immediate liquidity excluding inventory.
• Operating cash flow (TTM): ¥343.11 million - cash generated from core operations over the trailing twelve months.
• Free cash flow (TTM): ¥237.59 million - cash available after capital expenditures.
• Net change in cash (latest quarter): -¥382.58 million - quarter-over-quarter decrease in cash reserves.
• Altman Z-Score: 4.37 - low risk of bankruptcy based on the composite score.
• Piotroski F-Score: 5 - moderate financial strength based on profitability, leverage, liquidity, and operating efficiency signals.

• Liquidity profile: strong by ratios (Current 2.18, Quick 1.72) and positive operating/free cash flow on a TTM basis.
• Short-term cash movement: latest quarter shows a notable cash decline (-¥382.58M) - warrants review of cash uses (capex, debt repayments, M&A, or working capital shifts).
• Solvency and distress indicators: Altman Z-Score 4.37 supports low bankruptcy risk; Piotroski F-Score 5 signals room for operational or balance-sheet improvements.

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) Valuation Analysis

Key valuation metrics for Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) present a picture of a company trading at moderate multiples with an attractive forward earnings outlook and a modest income return to shareholders.

• Trailing twelve months (TTM) P/E: 14.81
• Forward P/E: 9.17 - implies expected earnings growth or improved profitability priced in by the market
• Price-to-Book (P/B): 1.82 - suggests the market values the company at nearly twice its book equity
• Price-to-Sales (P/S): 1.50 - indicates revenue is being valued at a modest premium
• Enterprise Value / EBITDA: 7.62 - a reasonable valuation relative to operating cash earnings
• Dividend yield: 2.08% with dividend per share of 0.20 CNY
• Earnings yield (TTM): 6.50% - inverse of the P/E, reflecting cash return potential relative to price
• Market capitalization (as of 2025-12-12): 8.71 billion CNY - down 10.76% over the last year

Valuation context and comparables can be explored further alongside ownership, earnings drivers and balance-sheet strength at: Exploring Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd Investor Profile: Who's Buying and Why?

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) Risk Factors

This section isolates the principal risks that could materially affect Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS)'s financial health, with quantification where available to help investors assess magnitude and sensitivity.

• Raw material price volatility: Xinjiang Xuefeng's primary inputs (ammonium nitrate, fuel oil blends, oxidizers and specialty chemicals) account for a large portion of COGS. A 10-20% move in benchmark chemical prices can change gross margin by an estimated 2-6 percentage points based on historical input-weighted sensitivities.
• Macroeconomic cycles impacting demand: Civil explosives and blasting services are closely tied to construction, mining and infrastructure spending. During slowdown scenarios, annual revenue can drop 15-30% in a single year in comparable peers; management has disclosed prior-year sensitivity indicating revenue declines of ~20% in regional downturns.
• Safety regulation and compliance cost pressure: Stricter safety production standards or new permitting frameworks typically result in one-time CAPEX and ongoing OPEX increases. Past regulatory upgrades in the industry have driven incremental annual compliance costs equal to 1-3% of revenue and CAPEX spikes of several hundred million RMB for multi-site operators.
• Cyclical end-market exposure: Key end-markets (mining, aggregates, infrastructure) are cyclical; concentration risk can cause revenue volatility and uneven utilization of production capacity. Single large contract cancellations have historically led to quarter-to-quarter revenue swings exceeding 25% in similar firms.
• International operations and geopolitical/currency risks: Export exposure and overseas joint ventures create FX translation risk and political risk. A 5% depreciation in RMB vs. major trade currencies or sanctions-related disruptions can reduce reported foreign-currency earnings and interrupt supply chains.
• Leverage and profitability trends: While reported debt levels have been modest historically, continued margin erosion can stress interest coverage. If EBITDA declines by 30% from recent levels, interest coverage could fall from low-double digits to the single digits, raising refinancing and covenant risk.

Key quantitative metrics (latest reported or management-discussed figures):

Operational and market risks broken down with investor-relevant considerations:

• Input cost pass-through: Contract structures vary-fixed-price contracts heighten exposure to raw-material inflation, while indexed contracts provide partial pass-through. Investors should track the share of fixed versus indexed contracts in backlog.
• Working capital and inventory build: Prolonged demand weakness can force inventory write-downs; days inventory outstanding (DIO) spikes would strain cash conversion cycles and may require short-term borrowing.
• Safety-related downtime: Major safety incidents or preemptive shutdowns for upgrades reduce capacity utilization; a multi-week stoppage at a plant can slice quarterly revenue by mid-teens percent.
• Customer concentration: A high proportion of sales to large mining or infrastructure groups increases counterparty risk-loss of one major customer could reduce sales materially in the short term.
• FX and cross-border flows: Hedging practices are relevant-insufficient hedging of foreign-currency receivables/payables increases earnings volatility when exchange rates move sharply.
• Refinancing and covenant exposure: Although current gross debt levels are modest, continued margin pressure could erode covenant headroom; monitor interest coverage and any near-term maturities.

Risk scenarios and potential impact (illustrative):

Practical monitoring checklist for investors:

• Quarterly gross margin and raw-material cost per tonne trends.
• Backlog composition: fixed-price vs. indexed contracts; customer concentration metrics.
• Capex and safety-related spend disclosures; timelines for required upgrades.
• Working capital trends: DSO, DPO and DIO movements and seasonal patterns.
• Leverage metrics: net-debt/EBITDA, interest coverage and upcoming debt maturities.

For further context on the company's history, ownership and how it operates, see: Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Xinjiang Xuefeng Sci-TechCo.,Ltd (603227.SS) - Growth Opportunities

• Acquisitions and capacity expansion: The February 2025 completion of the Xuefeng Sci-Tech acquisition increased explosive production capacity to 697,500 tons, strengthening regional leadership in Xinjiang.
• Service capability enhancement: The July 2025 acquisition of Shengshi Putian Technology Co., Ltd. is expected to broaden service offerings and after-sales capabilities, enabling cross-sell and bundled solutions.
• Revenue catalysts: A commercial collaboration with a major agricultural supplier is projected to open new sales channels and contribute an additional $3.0 million in revenues by 2025.
• R&D cost efficiency: Strategic partnerships with local universities for joint R&D are projected to reduce innovation costs by 25%, accelerating time-to-market for new formulations and safety technologies.
• Market positioning: Established brand reputation and strong in-house R&D provide a foundation to expand into adjacent markets (industrial explosives, mining services, agricultural cooperatives).
• Cost leadership and supply chain: Efficient supply chain management supports competitive pricing, preserving gross margins while enabling volume-driven market share gains.

• Short-term growth levers: monetize new channels (target $3M), integrate Shengshi Putian services, and optimize production utilization to improve fixed-cost absorption.
• Medium-term levers: leverage academic partnerships to lower R&D unit costs by ~25% and launch higher-margin specialty formulations; capture incremental market share in Xinjiang and neighboring provinces.
• Operational focus: maintain supply-chain efficiency to preserve cost leadership while scaling output toward full utilization of the 697,500‑ton capacity.